LAG3 and neoplasm: In particular, it is still an open question whether the immune-enhancing effects of HLB-apt are mediated through the blockade of inhibitory signal transduction pathways associated with LAG-3 or if they primarily function as a molecular bridge physically connecting Jurkat cells to tumor cells.